Results 161 to 170 of about 216,693 (188)

C3 nephritic factor associated with C3 glomerulopathy in children

Pediatric Nephrology, 2013
C3 glomerulopathy (C3G) is characterized by predominant C3 deposits in glomeruli and dysregulation of the alternative pathway of complement. Half of C3G patients have a C3 nephritic factor (C3NeF). C3G incorporated entities with a range of features on microscopy including dense deposit diseases (DDD) and C3 glomerulonephritis (C3GN).
Camille, Nicolas, Vincent, Vuiblet, Veronique, Baudouin, Marie-Alice, Macher, Isabele, Vrillon, Nathalie, Biebuyck-Gouge, Maud, Dehennault, Sophie, Gié, Denis, Morin, Hubert, Nivet, François, Nobili, Tim, Ulinski, Bruno, Ranchin, Maria Chiarra, Marinozzi, Stéphanie, Ngo, Véronique, Frémeaux-Bacchi, Christine, Pietrement   +16 more
openaire   +2 more sources

Pathogenesis of the C3 glomerulopathies and reclassification of MPGN

Nature Reviews Nephrology, 2012
Until recently, membranoproliferative glomerulonephritis (MPGN) was clinically classified as either primary, idiopathic MPGN or as secondary MPGN when an underlying aetiology was identifiable. Primary MPGN was further classified into three types--type I, type II, and type III--based principally on the ultrastructural appearance and location of electron-
Andrew S, Bomback, Gerald B, Appel
openaire   +2 more sources

C3 Glomerulopathy

The Biomedical & Life Sciences Collection, 2017
Jill J. Hauer, Carla M. Nester, Richard J. H. Smith   +2 more
openaire   +2 more sources

C3 Glomerulopathies

2023
Christoph Licht, Marina Vivarelli, Magdalena Riedl Khursigara, Patrick D. Walker   +3 more
openaire   +1 more source

C3 Glomerulopathy

2022
Pallav Gupta, Ramesh K. Gupta
openaire   +1 more source

C3-Glomerulopathie

Der Nephrologe, 2013
C.L. Bockmeyer, J.U. Becker
openaire   +1 more source

Lipoprotein Glomerulopathy, First Case Report from Canada

International Journal of Nephrology and Renovascular Disease, 2022
Maziar Riazy, Julie Ting, Sean Barbour
exaly  

Risk factors, histopathological features, and graft outcome of transplant glomerulopathy in the absence of donor-specific HLA antibodies

Kidney International, 2021
Dirk Kuypers, Maarten Coemans, Elisabet Van Loon   +2 more
exaly  

Efficacy and Safety of Iptacopan in Patients With C3 Glomerulopathy

Kidney International Reports, 2023
Teresa Cavero, Prasanna Kumar Nidamarthy
exaly  

A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy

Kidney International, 1999
Kengo Moriyama, Akira Matsunaga
exaly